Provided by Tiger Trade Technology Pte. Ltd.

Standard BioTools Inc.

1.16
-0.0350-2.94%
Volume:846.04K
Turnover:987.39K
Market Cap:444.17M
PE:-3.41
High:1.22
Open:1.22
Low:1.14
Close:1.19
52wk High:1.72
52wk Low:0.9200
Shares:384.57M
Float Shares:241.13M
Volume Ratio:0.94
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3384
EPS(LYR):-0.5234
ROE:-33.26%
ROA:-14.55%
PB:1.11
PE(LYR):-2.21

Loading ...

Binance Alpha will list Lab (LAB) for exclusive Token Generation Event (TGE) on October 14th.

Blockbeats
·
Oct 13, 2025

Cross-Chain Transaction Infrastructure LAB Teaser to be TGE on the 14th, Previously Raised $5 Million

Blockbeats
·
Oct 13, 2025

Standard BioTools to Cut 15% of Workforce Amid Restructuring

Dow Jones
·
Sep 18, 2025

Standard BioTools Inc - on Sept 13, Announces 15% Global Workforce Reduction - SEC Filing

THOMSON REUTERS
·
Sep 18, 2025

Casdin Partners Master Fund, L.P. Acquires Common Shares of Standard BioTools Inc

Reuters
·
Sep 12, 2025

BLOCKOFFICE ACQUIRES WEB3 MARKETING AGENCY POWERHOUSE- ACTIV8 LAB (PREVIOUSLY LYDIAN LABS)- ORGANISER OF MALAYSIA BLOCKCHAIN WEEK

prnewswire
·
Sep 11, 2025

Illumina Inc. Announces Agreement to Acquire SomaLogic, Expanding Its Footprint in the Proteomics Market

Reuters
·
Sep 08, 2025

Casdin Partners Master Fund, L.P. Acquires Common Shares of Standard BioTools Inc

Reuters
·
Sep 06, 2025

Illumina Inc. Launches Illumina Protein Prep Assay to Enhance Proteomics Discovery and Drive New Insights in Drug Development

Reuters
·
Sep 03, 2025

Illumina Expands Proteomics Market Presence with Acquisition of SomaLogic

Reuters
·
Sep 03, 2025

Illumina® Protein Prep Launches to Drive Greater Proteomic Insights for Improved Drug Discovery and Development

THOMSON REUTERS
·
Sep 03, 2025

Standard BioTools Inc: Expects Costs to Be Payable Over Next Several Months

THOMSON REUTERS
·
Sep 03, 2025

Standard BioTools Inc - Expects $3.6 Mln Expenses for Reduction-in-Force - SEC Filing

THOMSON REUTERS
·
Sep 03, 2025

Standard BioTools Inc - to Implement Reduction-in-Force in U.S. R&D - SEC Filing

THOMSON REUTERS
·
Sep 03, 2025

Standard BioTools Inc. Announces R&D Consolidation and Workforce Reduction in Strategic Reorganization Plan

Reuters
·
Sep 03, 2025

Casdin Partners Master Fund, L.P. Reports Acquisition of Common Shares in Standard BioTools Inc

Reuters
·
Aug 27, 2025

Casdin Partners Master Fund, L.P. Reports Acquisition of Common Shares of Standard BioTools Inc

Reuters
·
Aug 16, 2025